{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:08:31Z","timestamp":1744258111167,"version":"3.40.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10157-016-1281-9","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T18:26:11Z","timestamp":1463595971000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Masaki","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Momoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"1281_CR1","doi-asserted-by":"publisher","first-page":"c285","DOI":"10.1159\/000322278","volume":"118","author":"N Yanagisawa","year":"2011","unstructured":"Yanagisawa N, Ando M, Ajisawa A, Imamura A, Suganuma A, Tsuchiya K, Nitta K. Clinical characteristics of kidney disease in Japanese HIV-infected patients. Nephron Clin Pract. 2011;118:c285\u201391.","journal-title":"Nephron Clin Pract."},{"key":"1281_CR2","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1097\/QAD.0b013e3282ef1bb4","volume":"21","author":"CM Wyatt","year":"2007","unstructured":"Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, Klotman ME, Klotman PE. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21:2101\u20133.","journal-title":"AIDS."},{"key":"1281_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MAJ.0b013e31812e6b34","volume":"335","author":"SK Fernando","year":"2008","unstructured":"Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335:89\u201394.","journal-title":"Am J Med Sci"},{"key":"1281_CR4","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1093\/ndt\/gfm350","volume":"22","author":"CY Cheung","year":"2007","unstructured":"Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, Chau KF, Li CK, Li CS. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186\u201390.","journal-title":"Nephrol Dial Transplant"},{"key":"1281_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","volume":"24","author":"A Mocroft","year":"2010","unstructured":"Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD, EuroSIDA Study Group. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24:1667\u201378.","journal-title":"AIDS."},{"key":"1281_CR6","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.7448\/IAS.17.4.19514","volume":"17","author":"A Mocroft","year":"2014","unstructured":"Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L, Date on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group. A clinically useful risk-score for chronic kidney disease in HIV infection. J Int AIDS Soc. 2014;17:19514.","journal-title":"J Int AIDS Soc."},{"key":"1281_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/QAD.0b013e32834f337c","volume":"26","author":"J Young","year":"2012","unstructured":"Young J, Schafer J, Fux CA, Furrer H, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Weber R, Battegay M, Bucher HC, Swiss HIV Cohort Study. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS. 2012;26:567\u201375.","journal-title":"AIDS."},{"key":"1281_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0b013e3181be6be2","volume":"53","author":"M Horberg","year":"2010","unstructured":"Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, Chang J, Blank J, Quesenberry C Jr, Klein D. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010;53:62\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1281_CR9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archinte.161.11.1379","volume":"161","author":"SM Grundy","year":"2001","unstructured":"Grundy SM. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch Intern Med. 2001;161:1379\u201380.","journal-title":"Arch Intern Med"},{"key":"1281_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.amjcard.2005.06.044","volume":"96","author":"WR Farwell","year":"2005","unstructured":"Farwell WR, Sesso HD, Buring JE, Gaziano JM. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol. 2005;96:1129\u201334.","journal-title":"Am J Cardiol"},{"key":"1281_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","volume":"161","author":"Y Cui","year":"2001","unstructured":"Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413\u20139.","journal-title":"Arch Intern Med"},{"key":"1281_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.amjcard.2006.06.032","volume":"98","author":"J Liu","year":"2006","unstructured":"Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol. 2006;98:1363\u20138.","journal-title":"Am J Cardiol"},{"key":"1281_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/jama.298.7.776","volume":"298","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D\u2019Agostino RB, Vasan RS. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298:776\u201385.","journal-title":"JAMA"},{"key":"1281_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5551\/jat.1016","volume":"17","author":"H Noda","year":"2010","unstructured":"Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Ohta H. Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study. J Atheroscler Thromb. 2010;17:30\u20136.","journal-title":"J Atheroscler Thromb."},{"key":"1281_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.amjcard.2012.02.010","volume":"109","author":"N Mahajan","year":"2012","unstructured":"Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, Sudhakar R, Sagar A, Wang Y, Sacks F, Afonso L. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction. Am J Cardiol. 2012;109:1694\u20139.","journal-title":"Am J Cardiol"},{"key":"1281_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1179\/1743132813Y.0000000206","volume":"35","author":"J Wu","year":"2013","unstructured":"Wu J, Chen S, Liu L, Gao X, Zhou Y, Wang C, Zhang Q, Wang A, Hussain M, Sun B, Wu S, Zhao X. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study. Neurol Res. 2013;35:505\u201311.","journal-title":"Neurol Res"},{"key":"1281_CR17","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","volume":"12","author":"O Samuelsson","year":"1997","unstructured":"Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908\u201315.","journal-title":"Nephrol Dial Transplant"},{"key":"1281_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jacl.2012.01.008","volume":"6","author":"J Pan","year":"2012","unstructured":"Pan J, Gao F, Bao Y, Zhang L, Tu Y, Jia W. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters. J Clin Lipidol. 2012;6:382\u20137.","journal-title":"J Clin Lipidol."},{"key":"1281_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1281_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2307\/2529876","volume":"38","author":"NM Laird","year":"1982","unstructured":"Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963\u201374.","journal-title":"Biometrics."},{"key":"1281_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1281_CR22","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/sj.ki.5000270","volume":"69","author":"BR Hemmelgarn","year":"2006","unstructured":"Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155\u201361.","journal-title":"Kidney Int"},{"key":"1281_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/sj.ki.5000058","volume":"69","author":"BO Eriksen","year":"2006","unstructured":"Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375\u201382.","journal-title":"Kidney Int"},{"key":"1281_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1291\/hypres.31.433","volume":"31","author":"E Imai","year":"2008","unstructured":"Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res. 2008;31:433\u201341.","journal-title":"Hypertens Res"},{"key":"1281_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283313c91","volume":"23","author":"AI Choi","year":"2009","unstructured":"Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009;23:2143\u20139.","journal-title":"AIDS."},{"key":"1281_CR26","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1086\/587994","volume":"197","author":"GM Lucas","year":"2008","unstructured":"Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197:1548\u201357.","journal-title":"J Infect Dis"},{"key":"1281_CR27","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.2215\/CJN.09191010","volume":"6","author":"P Flandre","year":"2011","unstructured":"Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabi\u00e9 A, Poizot-Martin I, Katlama C, Brunet-Fran\u00e7ois C, Yazdanpanah Y, Dellamonica P, New AIDS Data group. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6:1700\u20137.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1281_CR28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/QAD.0b013e32827038ad","volume":"21","author":"GM Lucas","year":"2007","unstructured":"Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435\u201343.","journal-title":"AIDS."},{"key":"1281_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1053\/j.ajkd.2011.10.050","volume":"59","author":"V Jotwani","year":"2012","unstructured":"Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2012;59:628\u201335.","journal-title":"Am J Kidney Dis"},{"key":"1281_CR30","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1097\/QAD.0b013e3283320e12","volume":"23","author":"L Bansi","year":"2009","unstructured":"Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, Sabin C, Post FA, UK CHIC\/ESRF study group. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS. 2009;23:2517\u201321.","journal-title":"AIDS."},{"key":"1281_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1468-1293.2012.01045.x","volume":"14","author":"M Bickel","year":"2013","unstructured":"Bickel M, Marben W, Betz C, Khaykin P, Stephan C, Gute P, Haberl A, Knecht G, Wolf T, Brodt HR, Geiger H, Herrmann E, Jung O. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22\u00a0years. HIV Med. 2013;14:127\u201335.","journal-title":"HIV Med."},{"key":"1281_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1681\/ASN.V114669","volume":"11","author":"JA Joles","year":"2000","unstructured":"Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol. 2000;11:669\u201383.","journal-title":"J Am Soc Nephrol"},{"key":"1281_CR33","doi-asserted-by":"publisher","first-page":"e1001809","DOI":"10.1371\/journal.pmed.1001809","volume":"12","author":"A Mocroft","year":"2015","unstructured":"Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D:A:D study group, Royal Free Hospital Clinic Cohort, INSIGHT study Group, SMART study group, ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12:e1001809.","journal-title":"PLoS Med."},{"key":"1281_CR34","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1093\/ndt\/gfr129","volume":"26","author":"M Ando","year":"2011","unstructured":"Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients. Nephrol Dial Transplant. 2011;26:3923\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1281_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1053\/j.ajkd.2012.07.017","volume":"60","author":"Y Slinin","year":"2012","unstructured":"Slinin Y, Ishani A, Rector T, Fitzgerald P, MacDonald R, Tacklind J, Rutks I, Wilt TJ. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline. Am J Kidney Dis. 2012;60:747\u201369.","journal-title":"Am J Kidney Dis"},{"key":"1281_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1468-1293.2010.00855.x","volume":"12","author":"F Tordato","year":"2011","unstructured":"Tordato F, Cozzi Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, Castagna A, Nasta P, Ladisa N, Giacometti A, d\u2019Arminio Monforte A, Gori A, ICONA Foundation Study Group. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med. 2011;12:4\u201313.","journal-title":"HIV Med."},{"key":"1281_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jocd.2011.10.003","volume":"15","author":"B Buehring","year":"2012","unstructured":"Buehring B, Kirchner E, Sun Z, Calabrese L. The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV\u2013a pilot study using DXA total body composition analysis. J Clin Densitom. 2012;15:224\u201332.","journal-title":"J Clin Densitom."},{"key":"1281_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/cid\/ciu919","volume":"60","author":"AG Abraham","year":"2015","unstructured":"Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015;60:941\u20139.","journal-title":"Clin Infect Dis"},{"key":"1281_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1523-1755.2004.00865.x","volume":"66","author":"LA Szczech","year":"2004","unstructured":"Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145\u201352.","journal-title":"Kidney Int"},{"key":"1281_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1097\/00002030-200411050-00009","volume":"18","author":"CS Krawczyk","year":"2004","unstructured":"Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G Jr, HIV Outpatient Study Group. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS. 2004;18:2171\u20138.","journal-title":"AIDS."},{"key":"1281_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/ckj\/sfv015","volume":"8","author":"M Hara","year":"2015","unstructured":"Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M. Atazanavir nephrotoxicity. Clin Kidney J. 2015;8:137\u201342.","journal-title":"Clin Kidney J."},{"key":"1281_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.ackd.2009.07.009","volume":"17","author":"J Jao","year":"2010","unstructured":"Jao J, Wyatt CM. Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis. 2010;17:72\u201382.","journal-title":"Adv Chronic Kidney Dis."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-016-1281-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1281-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:04:41Z","timestamp":1744175081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-016-1281-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1281-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2016,5,18]]},"assertion":[{"value":"4 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}